bioMérieux dividend and valuation
Valuation
bioMérieux paid €0.98 per share in dividends over the last 12 months (yield 1.1%). Last ex-dividend date: June 9, 2026. The P/E ratio is 23.4. The average price target of 13 analysts is €89.04.
What would bioMérieux's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 21, 2026
bioMérieux compared with similar companies
bioMérieux's P/E (trailing 12 months): 23.4, −31% against the median of a group of 11 similar companies (33.9).
| Metric | bioMérieux | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 23.4 | 33.9 | 28.6 – 55.6 | Low |
| Forward P/E | 19.5 | 19.5 | 17.9 – 24.3 | Middle |
| EV/EBITDA | 9.94 | 19.5 | 12.4 – 23.3 | Low |
| Price/book | 2.50 | 4.09 | 2.56 – 5.63 | Low |
| Price/sales | 2.69 | 3.79 | 2.34 – 5.76 | Middle |
| Gross margin | 56.1% | 55.9% | 35.8% – 65.8% | Middle |
| Operating margin | 16.0% | 16.7% | 14.6% – 22.9% | Middle |
| Net margin | 11.6% | 9.9% | 6.2% – 15.1% | Middle |
| ROE | 11.2% | 11.2% | 6.9% – 14.6% | Middle |
| Debt/equity | 0.10 | 0.47 | 0.34 – 0.70 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
bioMérieux: valuation over time
On the latest fiscal year's earnings (2025), bioMérieux's P/E today is 27.3, in line with the median of its last 10 fiscal years (32.1; between 24.7 and 37.2 from 2016 to 2025). Relative to earnings, it costs about the same as in the past. The dividend yield (1.1%) is above the median of the last 10 fiscal years (0.7%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | €110.30 | €3.34 | 33.0 | €0.98 | 0.9% |
| 2024 | €103.50 | €3.64 | 28.4 | €0.90 | 0.9% |
| 2023 | €100.60 | €3.01 | 33.4 | €0.85 | 0.8% |
| 2022 | €97.92 | €3.82 | 25.6 | €0.85 | 0.9% |
| 2021 | €124.90 | €5.06 | 24.7 | €0.85 | 0.7% |
| 2020 | €115.40 | €3.41 | 33.8 | €0.62 | 0.5% |
| 2019 | €79.35 | €2.30 | 34.5 | €0.19 | 0.2% |
| 2018 | €57.50 | €2.17 | 26.5 | €0.35 | 0.6% |
| 2017 | €74.69 | €2.01 | 37.2 | €0.34 | 0.5% |
| 2016 | €47.30 | €1.51 | 31.3 | €0.33 | 0.7% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- €10.75B
- Enterprise value
- €10.45B
- PEG
- 2.10
- EV/revenue
- 2.62
Profitability and growth
- ROA
- 7.2%
- ROIC
- 8.7%
- Revenue growth (year over year)
- -3.9%
- Earnings growth (year over year)
- 41.9%
Financial health
- Total cash
- €657.7M
- Total debt
- €421.8M
- Current ratio
- 2.30
- Quick ratio
- 1.44
Dividends
- Annual dividend per share
- €0.98
- Dividend yield
- 1.1%
- Payout ratio
- 25.1%
- Ex-dividend date
- June 9, 2026
Analysts and estimates
- Average price target
- €89.04
- Median price target
- €86.00
- High price target
- €106.00
- Low price target
- €75.00
- Analysts with a price target
- 13
- Consensus
- Hold
- Forward EPS
- €4.69
- EPS estimate, current year
- €4.44
Shares and trading
- Beta
- 0.59
- Average volume
- 168.83K
- Shares outstanding
- 117.95M
- Float
- 40.02M
- Institutional ownership
- 15.2%
- Insider ownership
- 66.5%
